The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-institutional European phase I/II trial of trabectedin plus radiotherapy in metastaticsoft tissue sarcoma (STS) patients. A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study.
 
Javier Martin Broto
Consulting or Advisory Role - Bayer; Lilly; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - Eisai (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Antonio Lopez-Pousa
No Relationships to Disclose
 
Nadia Hindi
Research Funding - Eisai (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Josefina Cruz
No Relationships to Disclose
 
Javier Peinado
No Relationships to Disclose
 
Carlo Morosi
No Relationships to Disclose
 
Josep Isern
No Relationships to Disclose
 
Maria Carmen Dolado
No Relationships to Disclose
 
Rosa Maria Alvarez Alvarez
Honoraria - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; PharmaMar; Pierre Fabre
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Novartis; PharmaMar
Research Funding - Abbvie; AstraZeneca; Boehringer Ingelheim; Merrimack; Peregrine Pharmaceuticals; PharmaMar; Roche/Genentech; Samsung
Travel, Accommodations, Expenses - Bristol-Myers Squibb; PharmaMar; Roche
 
Ana Alvarez
No Relationships to Disclose
 
Giovanni Grignani
Research Funding - Lilly (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; PharmaMar
 
Marco Gatti
No Relationships to Disclose
 
Pablo Luna Fra
No Relationships to Disclose
 
Ignacio Alastuey
No Relationships to Disclose
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma
 
Marie-Pierre Sunyach
No Relationships to Disclose
 
Inmaculada Rincon
No Relationships to Disclose
 
Alessandro Gronchi
Honoraria - Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar
 
Jesus Romero
No Relationships to Disclose